Related Experiment Videos

Pre- and/or post-operative immunochemotherapy for advanced digestive cancer

S Saji¹, Y Sugiyama, K Kunieda

¹Second Department of Surgery, Gifu University School of Medicine, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy

|May 1, 1997

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Eribulin versus taxane as first-line chemotherapy combined with dual HER2 blockade in patients with HER2-positive locally advanced or metastatic breast cancer: final survival outcomes of the JBCRG-M06/EMERALD study.

ESMO open·2026

Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Association between adjuvant chemotherapy and outcomes in resected locoregional recurrence of hormone receptor-positive HER2-negative breast cancer: a multi-institutional retrospective study.

ESMO open·2025

Effectiveness of polypharmacy measures consisting of a pharmacist check followed by a multidisciplinary team review in patients with poly-pharmacy admitted to a neurology ward.

Die Pharmazie·2025

Fracture resistance and failure-modes of endocrowns with two margin designs (butt versus shoulder) in primary molars: an in vitro study.

European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry·2025

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer.

ESMO open·2024

See all related articles